Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Usefulness of 123I-MIBG Scintigraphy in the Evaluation of Patients with Known or Suspected Primary or Metastatic Pheochromocytoma or Paraganglioma: Results from a Prospective Multicenter Trial
The Journal of Nuclear Medicine, 08/26/09
Wiseman GA et al. – This prospective study demonstrated a sensitivity of 82%–88% and specificity of 82%–84% for 123I–MIBG imaging used in the diagnostic assessment of primary or metastatic pheochromocytoma or paraganglioma.
Related Articles
Comparison of 18F-Fluoro-L-DOPA, 18F-Fluoro-Deoxyglucose, and 18F-Fluorodopamine PET and 123I-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma
Journal of Clinical Endocrinology and Metabolism, 11/12/09
Relevance Score: 80%
Today in Nuclear Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Perioperative 18F-fluorodeoxyglucose-guided imaging using the becquerel as a quantitative measure for optimizing surgical resection in patients with advanced malignancy
The American Journal of Surgery, 12/11/09
Verification of Musculoskeletal FDG-PET-CT Findings Performed for Melanoma Staging
Annals of Surgical Oncology, 12/10/09
Impact of Multiphase 68Ga-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors
Neuroendocrinology, 12/09/09
Sponsor
Article Search
Sponsor


See Latest Articles


